International Journal of Trend in Scientific Research and Development (IJTSRD)
Volume 5 Issue 1, November-December 2020 Available Online: www.ijtsrd.com e-ISSN: 2456 – 6470
Microspheres and Kinds
Sakshi Ghuge1, Prof. Smita More2
1Pharmaceutics,
Modern College of Pharmacy (for Ladies), Pune, Maharashtra, India
Phule Pune University, Pune, Maharashtra, India
2Savitribai
ABSTRACT
Background: The concept of targeted drug delivery is meant for attempting to
concentrate the drug within the tissues of interest while reducing the relative
concentration of the medication within the remaining tissues.
KEYWORDS: Microspheres, methods, types
How to cite this paper: Sakshi Ghuge |
Prof. Smita More "Microspheres and
Kinds" Published in
International Journal
of Trend in Scientific
Research
and
Development (ijtsrd),
ISSN:
2456-6470,
Volume-5 | Issue-1,
IJTSRD35866
December
2020,
pp.133-141,
URL:
www.ijtsrd.com/papers/ijtsrd35866.pdf
Now each day the recent development in new drug delivery systems plays a
significant role in pharmaceutical industries. As a result, drug is localized on
the targeted site. Hence, surrounding tissues aren't plagued by the drug. So,
carrier technology offers an intelligent approach for drug delivery by coupling
the drug to a carrier particle like microspheres, nanoparticles, liposomes,
niosomes etc which modulates the discharge and absorption characteristics of
the drug. Microspheres are characteristically free flowing powders consisting
of proteins or synthetipolymers which are biodegradable in nature and ideally
having a particle size but 200 μm. it's the reliable means to deliver the drug to
the target site with specificity, if modified, and to take care of the specified
concentration at the location of interest without untoward effects.
Copyright © 2020 by author(s) and
International Journal of Trend in Scientific
Research and Development Journal. This
is an Open Access article distributed
under the terms of
the
Creative
Commons Attribution
License
(CC
BY
4.0)
Microspheres received much attention not just for prolonged release, but also
for targeting of anticancer drugs to the tumor. In future by combining various
other strategies, microspheres will find the central place in novel drug
delivery, particularly in diseased cell sorting, diagnostics, gene & genetic
materials, safe, targeted and effective in vivo delivery and supplements as
miniature versions of diseased organ and tissues within the body.
Microspheres are free flowing powder that comprises proteins or synthetic
polymers that are biodegradable in nature ranging between 1-1000nmin size.
A neat controlled drug delivery system can overcome a number of the issues of
conventional therapy and enhance the therapeutic efficacy of a give drug.
There are various approaches in delivering a therapeutic substance to the
target site in a very sustained controlled release fashion. Among them
microspheric drug delivery system has gained enormous attention because of
its wide selection of application because it covers targeting the drug to
particular site to imaging and helping the diagnostic features. the aim of the
review is to compile various sorts of microspheres, different methods to
preparation, its applications and also various parameters to guage their
efficiency.
(http://creativecommons.org/licenses/by/4.0)
Materials and methods: there are differnt methods of preparation of
microspheres:
1. Bio adhesive microspheres
2. Magnetic microspheres
3. Floating microspheres
4. Radioactive microspheres
5. Polymeric microspheres
i) Biodegradable polymeric microspheres
ii) Synthetic polymeric
Result: from this review, we are able to prepared micropsheres by using
differing kinds of method of preparation.
Conclusion: From this review, we could conclude that various sorts of
preparation methods together with its pharmaceutical application are being
employed for Microspheres as a drug delivery system for delivering the
definite amount of medicines in a very controlled manner. it's going to include
oral, targeted, sustained, topical, naso-pulmonary and various biotechnology
applications like gene therapy etc. By developing newer delivery technologies,
it can give way more therapeutic and commercial benefits by improving the
security and reducing the toxicity. By this we can prepared t microspheres by
using different method of preparation
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
Volume – 5 | Issue – 1
|
November-December 2020
Page 133
International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
INTRODUCTION
Microparticles, microspheres, and microcapsules are
common constituents of multiparticulate drug delivery
systems opening numerous advantages supported their
structural and functional abilities and their application is
suitable for convenient and tolerable drug administration via
several routes .Depending on the formulation, they'll be
incorporated into different pharmaceutical dosage
forms like solids (capsules, tablets, sachets), semisolids (gels,
creams, pastes), or liquids (solutions, suspensions, and even
parenterals).
Drug delivery systems (DDS) that may precisely control the
discharge rates or target drugs to a selected body site have
had an unlimited impact on the health care system. the
perfect drug delivery system delivers drug at rate decided
by the necessity of the body throughout the amount of
treatment and it provides the active entity solely to the
positioning of action. So, carrier technology offers an
intelligent approach for drug delivery by coupling the drug
to a carrier particle like microspheres, nanoparticles,
liposome's, etc which modulates the discharge and
absorption characteristics of the drug.1 sorts of drug
delivery system are;
LIPOSOME
NIOSOME
NANOPARTICAl
MICROSPHERE
Multiparticulate drug delivery systems offer outstanding
advantages to experts and patients, such as:
choice of dosage form for the specified drug delivery
route (per oral tablets, parenteral injections);
modified and targeted (even site-specific) drug release
and delivery;
more expectable pharmacokinetics with reduced intraor inter-subject variability;
more homogenous distribution within the physiological
environment;
stable fixed-dose combinations of drugs;
dose titration and fewer dose-dumping
patient centricity through better compliance (e.g.,
patients with dysphasia) and adherence;
individual therapy (e.g., for pediatric or geriatric
population);
improving stability of the medicinal preparations;
isolating the constituents to make sure better
compatibility;
innovative products with a protracted life cycle through
patent protection
The drug has got to be delivered for a protracted period of
your time and lots of medicines need to be taken
simultaneously just in case of chronic patients. Frequent
administration of drug is critical when those have shorter
half-life and everyone these ends up in decrease patient’s
compliance. In order to beat the above problems,
various kinds of controlled release dosage forms are
formulated and altered, so patient compliance increase
through prolonged effect, adverse effect decreases by
lowering peak plasma concentration. The controlled release
dosage form maintaining relatively constant drug
level within the plasma by releasing the drug at a
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
predetermined rate for an extended period of your time.
Further, currently available slow release oral dosage forms,
such as enteric coated/ double-layer tablets which release
the drug for 12-24 hours still end in inefficient systemic
delivery of the drug and potential gastrointestinal irritation
Microencapsulation for oral use has been employed to
sustain the drug release, and to cut back or eliminate channel
irritation. Additionally, multiparticulate delivery systems
detached more uniformly within the channel. This leads
to more reproducible drug absorption and reduces local
irritation compared to single-unit dosage forms like no
disintegrating, polymeric matrix tablets. Unwanted intestinal
retention of the polymeric material, which can occur with
matrix tablets on chronic dosing, may also be avoided. Thus,
microencapsulation technique has been accustomed modify
and retard drug.
Ideal Characteristics of Microspheres:
A. Ability to regulate the discharge rate for a predefined
period of your time
B. Higher
concentrations
of
the
drug are
often given function depot.
C. Stability of the preparation after synthesis with a
clinically acceptable period.
D. Controlled particle size and dispersion of the drug in
aqueous solvent for parenterals.
E. Biocompatibility with a controllable biodegradability
Advantages of Microspheres:
Size reduction ends up in increase in expanse which
might enhance solubility of the poorly soluble drug.
Provide constant drug concentration in blood which
might increase patent compliance,
Decrease dose and toxicity.
Coating of drug with polymers helps the drug from
enzymatic cleavage hence found to be best for drug
delivery.
Less dosing frequency ends up in better patient
compliance.
Better drug utilization will improve the bioavailability
and reduce the incidence or intensity of adverse effects.
Protects the GIT from irritant effects of the drug.
Convert liquid to solid form and to mask the bitter taste.
Reliable means to deliver the drug to the target site with
specificity, if modified, and to take care of the
required concentration at the positioning of interest
without untoward effects.
Reduce the reactivity of the core in respect to the
skin environment.
Biodegradable microspheres have the advantage over
large polymer implants in this they are doing not
require surgical procedures for implantation and
release.
Controlled release delivery biodegradable microspheres
are wont to control drug release rates thereby
decreasing toxic side effects, and eliminating the
inconvenience of repeated injections 10.
Limitation: a number of the disadvantages were found
to be as follows 5
1.
2.
the prices of the materials and processing of the
controlled
release
preparation
are
substantially over those of normal formulations.
The fate of polymer matrix and its effect on the
environment.
Volume – 5 | Issue – 1
|
November-December 2020
Page 134
International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
3.
4.
5.
6.
1.
2.
3.
4.
5.
The fate of polymer additives like plasticizers,
stabilizers, antioxidants and fillers.
Reproducibility is a smaller amount.
Process conditions like change in temperature, pH,
solvent addition, and evaporation /agitation may
influence the soundness of core particles to be
encapsulated.
The environmental impact of the degradation products
of the polymer matrix produced in response to heat,
hydrolysis, oxidation, radiation or biological agents.
Types of Microspheres:
Bio adhesive microspheres
Magnetic microspheres
Floating microspheres
Radioactive microspheres
Polymeric microspheres
i. Biodegradable polymeric microspheres
ii. Synthetic polymeric
1. Bioadhesive / Mucoadhesive Microspheres:
Adhesion could also be defined as sticking property of drug
to the mucosal membrane by using water soluble polymers
11, 12. Adhesion of drug delivery device to the mucosal
membrane like buccal, ocular, rectal, nasal etc. may
be termed as bio adhesion. These styles of microspheres
exhibit a protracted contact time at the positioning of
application and causes intimate contact with the absorption
site and produces better therapeutic action. Or
Bioadhesion could also be defined because the process by
which a natural or synthetic polymer can adhere to a
biological membrane. When the biological membrane may be
a mucosal layer then it's referred to as mucoadhesion.
Mucoadhesion may be a currently utilized in the planning of
recent drug delivery system.
Mucoadhesive microspheres
provide a protracted contact time at the positioning of
application or absorption and helps in facilitating an
intimate contact with the underlying surface at which
absorption is suppose to be occurred and thereby improve
or better to therapeutic performance of drug. Mucoadhesive
polymer are accustomed improving drug delivery by
promoting the duration and make contact with time of the
dosage form with the mucous membranes, it adhere the
mucosal surface within the body and also the drug
absorption by mucosal cells could also be enhanced or
released at the positioning for an extended period of your
time and enhanced bio availability of the drug to high surface
to volume ratio. In recent years such mucoadhesive
microspheres are developed for oral, buccal, nasal, ocular,
rectal, vaginal routes for either systemic or local effects 13.
Theories of Mucoadhesion:
The phenomenon of bio adhesion occurs by a
posh mechanism. Many scientists have worked over
bioadhesion; till date six theories are proposed which
might improve our understanding for phenomenon of
adhesion and might even be extended to clarify the
mechanism of bioadhesion. The theories include like
molecules.
The electronic theory proposes transfer of electrons
amongst the surface leading to the formation of an electrical
double layer there by giving attractive forces.
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
A. The wetting theory postulates that if the contact angle of
liquids on the substrate surface is lower, then there's a
greater affinity for the liquid to the substrate surface.
B. The adsorption theory proposes the presence of
intermolecular forces, viz. hydrogen bonding and
Vanderwaal’s forces, for the adhesive interaction
amongst the substrate surfaces.
C. The diffusion theory assumes the diffusion of the
polymer chains, present on the substrate surfaces,
across the adhesive interface thereby forming a
networked structure.
D. The mechanical theory explains the diffusion of the
liquid adhesives in to the micro cracks and irregularities
present on the substrate surface there by forming an
interlocked structure which produce to adhesion.
E. The cohesive theory proposes that the phenomena of
bio adhesion are mainly thanks to the intermolecular
interactions.
2. Magnetic Microspheres:
In this larger amount of freely circulate drug are
often replaced by smaller amount of magnetically targeted
drug which receive magnetic responses to a flux from
incorporated materials that are used for magnetic
microspheres are chitosan, dextran etc. Magnetic
microspheres hold great promise for reaching the goal of
controlled and site specific drug delivery. Magnetic
microspheres as an alternate to traditional radiation
methods which uses highly penetrating radiations that's
captivated throughout the body. Its use is restricted by
toxicity and side effects. Now days, several embattled
treatment systems including flux, force field, ultrasound,
temperature, UV light and involuntary force are being
employed in many disease treatments (e.g. cancer, nerve
damage, heart and artery, anti-diabetic, eye and other
medical treatments). Among them, the magnetic targeted
drug delivery system is one among the foremost attractive
and promising strategy for delivering the drug to the
required site. Magnetically controlled drug targeting is one
among the assorted possible ways of drug targeting. This
technology relies on binding establish anticancer drug with
ferrofluid that concentrate the drug within the area of
interest (tumor site) by means of magnetic fields. There has
been keen interest within the development of a magnetically
target drug delivery system. These drug deliv drug at a rate
directed by the requirements of the body during the
amount of treatment, and target the activity entity to the
positioning of action.
The differing types of magnetic microspheres are as
follows:
A. Therapeutic magnetic microspheres wont to deliver
chemotherapeutic agent to liver tumour. Drugs like
proteins and peptides can even be targeted through this
method.
B. Diagnostic microspheres, used for imaging liver
metastases and can also be wont to distinguish bowel
loops from other abdominal structures by forming
nanosize particles supra magnetic iron oxides.
3. Floating Microspheres:
Gastro retentive drug delivery via floating types having
advantages of bulk density is a smaller amount than the
gastric fluid then remains buoyant in stomach without
affecting gastric emptying rate. The drug is released slowly
Volume – 5 | Issue – 1
|
November-December 2020
Page 135
International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
at the specified rate, and also the system is found to be
floating on gastric content and increases gastric residence
and increases fluctuation in plasma concentration. Moreover
it also reduces chances of dose dumping. It produces
prolonged therapeutic effect and so reduces dosing
frequencies. Few drugs like Famotidine could also
be given within the sort of floating microspheres depending
upon the pharmacokinetic properties 19 - 22.
4. Radioactive Microspheres:
Radio embolization therapy microspheres sized 10-30 nm
are of larger than the diameter of the capillaries and gets
tapped in first animal tissue once they encounter 3,
21. they're injected within the arteries that leads them to
tumour of interest so of these conditions radioactive
microspheres deliver high radiation dose to the targeted
areas without damaging the conventional surrounding
tissues. It differs from drug delivery system, as radio
activity isn't released from microspheres but acts from
within a radioisotope typical distance and also
the different styles of radioactive microspheres are α
emitters, β emitters, γ emitters.
5. Mucoadhesive microspheres:
Mucoadhesive microspheres which are of 1-1000mm in
diameter and consisting either entirely of a mucoadhesive
polymer or having an outer coating of it and coupling of
mucoadhesive properties to microspheres has additional
advantages, e.g. efficient absorption and enhanced
bioavailability of ery systems the drugs thanks to a high
surface to volume ratio, a way more intimate contact with
the mucus layer, specific targeting of drug to the absorption
site achieved by anchoring plant lectins, bacterial adhesions
and antibodies, etc. on the surface of the microspheres.
Mucoadhesive microspheres will be tailored to stick to any
mucosal tissue including those found in eye, cavum, urinary
and canal, thus offering the probabilities of localized yet as
systemic controlled release of medication.
6. Polymeric microspheres:
The different types of polymeric microspheres will
be classified as,
1. Biodegradable polymeric microspheres:
Natural polymers like starch are used with the concept that
they're biodegradable, biocompatible, and also Bioadhesive
in nature. Biodegradable polymers prolongs the continuance
when contact with membrane thanks to its high degree of
swelling property with aqueous medium, results gel
formation. the speed and extent of drug release is controlled
by concentration of polymer and also the release pattern in a
very sustained manner. the most drawback is, in clinical use
drug loading efficiency of biodegradable microspheres is
complex and is difficult to manage the drug release.
2. Synthetic polymeric microspheres:
The interest of synthetic polymeric microspheres are
widely employed in clinical application, moreover that also
used as bulking agent, fillers, embolic particles, drug delivery
vehicles etc and proved to be safe and biocompatible. But the
most disadvantage of those quite microspheres, are tend to
migrate removed from injection site and result in potential
risk, embolism and further organ damage.
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
Materials and methodsϖ
Microspheres used usually are polymers.ϖ they're classified
into two types:
1. Synthetic Polymers
2. Natural
polymers
Synthetic polymers are divided into two types:
A. Non-biodegradable
polymers:
Polymethyl methacrylate (PMMA), Acrolein, Glycidyl
methacrylate, Epoxy polymers.
B. Biodegradable polymers Lactides, Glycolides & their co
polymers, Poly alkyl cyanoacrylates, Poly anhydrides
Natural polymers obtained from different sources like
proteins, carbohydrates and chemically modified
carbohydrates.
Proteins: Albumin, Gelatin, Collagen
Carbohydrates: Agarose, Carrageenan, Chitosan, Starch
Chemically modified carbohydrates: Poly dextran, Poly
starch.
METHODS OF PREPERATION:ϖ
Emulsion solvent evaporation technique
Emulsion cross linking method Coacervation method
Spray drying technique
Emulsion-solvent diffusion technique
Multiple emulsion method
Ionic gelation
Hydroxyl appetite (HAP) microspheres in sphere
morphology
Preparation of microspheres should satisfy certain
criteria:¬
1. the power to include reasonably high concentrations of
the drug.
2. Stability of the preparation after synthesis with a
clinically acceptable period.
3. Controlled particle size and dispersibility in aqueous
vehicles for injection.
4. Release of active reagent with a decent control over a
good continuance
5. Biocompatibility with a controllable biodegradability
and
6. Susceptibility to chemical modification
1. Emulsion solvent evaporation technique:
In this technique the drug is dissolved in polymer which was
previously dissolved in chloroform and also the resulting
solution is added to aqueous phase containing 0.2 % sodium
of PVP as emulsifying agent. The above mixture was agitated
at 500 rpm then the drug and polymer (eudragit) was
transformed into fine droplet which solidified into rigid
microspheres by solvent evaporation then collected by
filtration and washed with demineralised water and
desiccated at temperature for twenty-four hrs. Aceclofenac
microspheres were prepared by this method.ai
2. Emulsion cross linking method:
In this method drug was dissolved in aqueous gelation
solution which was previously heated for 1 hr at 40oC. the
answer was added drop wise liquid paraffin while stirring
the mixture at 1500 rpm for 10 min at 35oC, leads to w/o
emulsion then further stirring is completed for 10 min at
15oC. Thus the produced microspheres were washed
Volume – 5 | Issue – 1
|
November-December 2020
Page 136
International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
respectively 3 times with acetone and isopropanol which
then air dried and dispersed in 5mL of aqueous
glutaraldehyde saturated toluene solution at temperature for
3 hrs for cross linking so was treated with 100mL of 10mm
glyciene solution containing 0.1%w/v of tween 80 at
37oC for 10 min to dam un reacted glutaraldehyde. Examples
for this method is Gelatin microspheres.
3. Coacervation method:
Coacervation thermal change: Performed by weighed
amount of ethyl cellulose was dissolved in cyclohexane with
vigorous stirring at 80oC by heating. Then the drug finely
pulverized and added with vigorous stirring on the above
solution and phase separation was done by reducing
temperature and using ice bath. Then above product was
washed twice with cyclohexane and air dried then
competent sieve (sieve no.40) to get individual
microcapsule.
4. Coacervation non solvent addition:
Developed by weighed amount of ethyl cellulose was
dissolved in toluene containing propylisobutylene in closed
beaker with magnetic stirring for 6 hr at 500 rpm and
therefore the drug is dispersed in it and stirring is
sustained for 15mins. Then phase separation is completed
by petroleum benzoin.14 times with continuous stirring. at
the moment the microcapsules were washed with n-hexane
and air dried for two hr so in oven at 50oC for 4 hr.
5. Spray drying technique:
This was accustomed prepare polymeric blended
microsphere loaded with ketoprofen drug. It involves
dispersing the core material into liquefied coating
material so spraying the mixture within the environment for
solidification of coating followed by rapid evaporation of
solvent. Organic solution of poly (epsilon caprolactone)
(PCL) and cellulose ester butyrate (CAB), in numerous
weight ratios and ketoprofen were prepared and sprayed in
numerous experimental condition achieving drug loaded
microspheres. this can be rapid but may loose crystalinity
because of fast drying process.
6. Emulsion-solvent diffusion technique:
In order to enhance the duration in colon floating
microparticles of ketoprofen were prepared using emulsion
solvent diffusion technique. The drug polymer mixture was
dissolved during a mixture of ethanol and dichloromethane
(1:1) so the mixture was added drop wise sodium lauryl
sulphate (SLS) solution. the answer was stirred with
propeller type agitator at temperature at 150 rpm for 1 hr.
Thus the formed floating microspheres were washed and
dried during a desiccators at temperature. The subsequent
microparticles were sieved and picked up.
7. Multiple emulsion method:
Oral controlled release drug delivery of indomethacin was
prepared by this method. Within the beginning powder drug
was dispersed in solution (methyl cellulose) followed by
emulsification in ethyl cellulose solution in ester. the
first emulsion was then re emulsified in aqueous medium.
Under optimized condition discrete microspheres were
formed during this phase.
8. Ionic gelation:
Alginate/chitosan particulate system for NSAID release was
prepared using this method. 25% (w/v) of NSAID was added
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
to 1.2% (w/v) solution of sodium alginate. so as to
induce the whole solution stirring is sustained and at the
moment it had been added drop wise an answer containing
Ca2+ /Al3+ and chitosan solution in carboxylic acid.
Microspheres which were formed were kept in original
solution for twenty-four hr for internal gellification followed
by filtration for separation. the whole release was obtained
at pH 6.4-7.2 but the drug didn't release in acidic pH.
9. Hydroxyl appetite (HAP) microspheres:
In microsphere morphology this was accustomed prepare
microspheres with peculiar spheres in sphere morphology
microspheres were prepared by o/w emulsion followed by
solvent evaporation. initially o/w emulsion was prepared by
dispersing the organic phase (Diclofenac sodium containing
5%w/w of EVA and appropriate amount of HAP) in aqueous
phase of surfactant. The organic phase was dispersed within
the style of tiny droplets which were surrounded by
surfactant molecules this prevented the droplets from cosolvencing and helped them to remain individual droplets.
While stirring the DCM was slowly evaporated and therefore
the droplets solidify individual to become microspheres.
Evaluation of Microspheres:
1. Particle size analyzer:
Microsphere (50 mg) are suspended in H2O (5mL)
containing 2%w/v of tween 80, to stop microsphere
aggregation, the above suspension is sonicated in water
bath and therefore the particle size is expressed as volume
mean diameter in micrometer.
2. Optical microscopy
This method is employed to work out particle size by using
optical microscope (Meizer OPTIK) The measurement i done
under 450x (10x eye piece and 45x objective) and100
particles are calculated.
3. Scanning microscopy (SEM)
Surface morphology is decided by the tactic SEM. during
this microcapsule are mounted directly on the SEM sample
slab with the assistance of double sided sticking tape and
coated with gold film under reduced pressure and analyzed.
4. Swelling index:
This technique is employed for characterization of sodium
alginate microspheres. Different solution (100mL) are
taken like [distilled water, solution of Ph (1.2, 4.5, 7.4)] and
alginate microspheres (100mg) are placed during a wire
basket and kept on the above solution and swelling is
allowed at 37oC. Thus, changes in weight variation between
initial weight of microspheres and weight thanks to swelling
is measured by taking weight periodically and soaking
with paper.
5. Entrapment efficiency:
Microspheres containing of drug (5mg) are crushed and
so dissolved in H2O with the assistance of ultrasonic stirrer
for 3 hr, filtered then assayed by uv-vis spectroscopy.
Entrapment efficiency is capable ratio of actual drug content
to theoretical drug content.
6. X-ray diffraction:
Change in crystalinity of drug will be determined by this
method. Microparticles and its individual components are
analyzed by the assistance of XRD Instrument. Scanning
range angle between 80oC - 70oC.
Volume – 5 | Issue – 1
|
November-December 2020
Page 137
International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
7. Thermal analysis:
Thermal analysis of microcapsule and its component will be
done by using
1. Differential scanning calorimetry (DSC)
2. Thermo quantitative analysis (TGA)
3. Differential
thermometric
analysis
(DTA)
Accurately the sample is weighed and heated on alumina
pan at constant rate of 10oc/min under nitrogen flow of
40 ml/min.
8. Zeta potential:
The polyelectrolyte shell is ready by incorporating
chitosan of various mass into the W2 phase and therefore
the resulting particles are determined by zeta potential
measurement.
9. Vaginal drug delivery:
Polymer, modified by the introduction of thioglycolic acid
to the first amino groups of the polymer, embeds
clotrimazole, animidazole derivative, is widely used for the
treatment of mycotic infections of the genitourinary tract. By
introducing thiol groups, the mucoadhesive properties of the
polymer are strongly improved and this can be found to
extend the continuance of the vaginal mucosa tissue (26
times longer than the corresponding unmodified polymer),
guaranteeing a controller drug release within the treatment
of mycotic infections. Vaginal tablets of polymer containing
metronidazole and acriflavine have showed adequate release
and good adhesion properties.
10. Colonic drug delivery:
Polymer has been used for the precise delivery of insulin to
the colon. The chitosan capsules were coated with enteric
coating (Hydroxy propyl methyl cellulose phthalate)and
contained,apart from insulin, various additional absorption
enhancer and enzyme inhibitor. it absolutely was found that
capsules specifically disintegrated within the colonic
region. it absolutely was suggested that this disintegration
was thanks to either the lower pH within the colon as
compared to the terminal ileum or to the presence bacterial
enzyme, which might degrade the polymer.
11. Cosmetics industry:
Cosmetic compositions are disclosed for the treatment of
hair or skin, characterized by a content of recent quaternary
chitosan derivatives of the formula. The chitosan derivatives
have an honest substantial, particularly to hair keratin,
and convince have hair strengthening and hair conditioning
characteristics. e.g.; Hair setting lotion, Oxidation Haircoloring Composition, Hair toning composition, skin cream,
hair treatment composition, gel form.
12. Dental Medicine:
Chitosan are recognized to accelerate wound healing to
achieve an aesthetically valid skins face, and to forestall
excess scar formation. In medical specialty, chitosan is
additionally applied as a dressing for oral mucous wound
and a tampon following radical treatment of maxillary
sinusitis. Furthermore, it's being investigated as an
absorbing membrane for periodontal surgery.
Chitosan features a kind of biological activities and
advertised as a healthy food that's effective for improvement
and/or care of varied disorders, arthritis, cancer,diabetes,
hepatitis, etc.
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
13. Effect of chitosan:
acid ratio on drug Release it's been demonstrated that
polymer with appropriate viscosity and expanding
property may be used as osmotic agents for the discharge of
water-insoluble drug. thanks to its high mass and a linear
unbranched structure, chitosan is totally biodegradable,
toxicologically harmless and low cost, and exhibits a
superb gelation characteristic. Hence the potential for
chitosan to be used as a polymeric osmotic agent in osmotic
pump is clear. The hydration and gel formation of chitosan
are a great deal hooked in to the pH of surroundings. it's
insoluble at an alkaline and neutral pH but soluble at acid
condition. Upon dissolution, amine groups of the polymer
become protonated, forming a resultant viscous and soluble
polysaccharide.
Inclusion
of acid as
pHregulating
excipient within the developed formulations was expected to
decrease the micro environmental pH of the core to an
appropriate level at which chitosan could form appropriate
viscous gelling solution and hence, to reinforce the pressure
of core tablets.
14. Gene delivery:
Gene delivery systems include viral vectors, cationic
liposomes, polycation complexes, and microencapsulated
systems. Viral vectors are advantageous for gene delivery
because they're highly efficient and have a good range of cell
targets. However, when employed in vivo they cause
immune responses and oncogenic effects. to beat the
restrictions of viral vectors, non-viral delivery systems are
considered for gene therapy. Non-viral delivery system has
advantages like easy preparation, cell/tissue targeting,
low immunologic response, unrestricted plasmid size, and
large-scale reproducible production. Polymer has been used
as a carrier of DNA for gene delivery applications. Also,
polymer may well be a useful oral gene carrier thanks to its
adhesive and transport properties within the duct.
15. Oral drug delivery:
The potential of polymer films containing diazepam as an
oral drug delivery was investigated in rabbits. The results
indicated that a movie composed of a 1:0.5 drug-polymer
mixture may well be an efficient dosage form that's
appreciate the commercial tablet dosage forms. the power of
polymer to make films may permit its use within the
formulation of film dosage forms, as another to
pharmaceutical tablets. The pH sensitivity, coupled with the
reactivity of the first amine groups, make polymer a
novel polymer for oral drug delivery applications.
16. Buccal drug delivery:
Buccal tablets supported chitosan microspheres containing
chlorhexidine diacetate gives prolonged release of the
drug within the bodily cavity improving the antimicrobial
activity of the drug. Polymer microparticles with no drug
incorporated have antimicrobial activity thanks to the
polymer. The buccal bilayered devices (bilaminated films,
palavered tablets) employing a mixture of drug.(nifedipine
and propranolol hydrochloride) and chitosan, with or
without anionic cross linking polymers (polycarbophil,
sodium alginate, gellan gum) has promising potential to be
used in controlled oral drug delivery system.
17. FTTR:
The drug polymer interaction and also degradation of drug
while processing for microencapsulation may be determined
by FTIR.
Volume – 5 | Issue – 1
|
November-December 2020
Page 138
International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
18. Stability studies
Stability Studies are done by placing the microspheres in
screw capped glass container and storing them at following
conditions:
Ambient humid condition
Room temperature (27+/-2 oC)
Oven temperature (40+/-2 oC)
Refrigerator (5 0+/-8 oC).
It was disbursed of for 60 days and also the drug content of
the microsphere is analyzed.
19. Transdermal Drug Delivery:
Polymer has good film-forming properties. The drug release
from the devices is stricken by the membrane thickness and
cross-linking of the film. e.g. Chitosan, Alginate, PLGA.
20. Monoclonal Antibodies:
Monoclonal antibodies or targeting microspheres are
biologically immune microspheres. this kind of targeting is
employed to attain selective targeting to specific sites of the
body organ. Monoclonal Antibodies are extremely specific
molecules which bind to the precise a part of the body
system through which absorption takes place via
A. Non specific adsorption and specific adsorption
B. Direct coupling
C. Coupling via reagents
21. Medical Application:
Release of proteins, peptides and hormones over the
extended period of your time.
Passive targeting of leaky tumor vessels, active targeting
of tumor cells, antigens, by parenteral route.
Magnetic Microspheres are often used for used
for vegetative cell extraction and bone marrow purging.
Used for Various assay for communicable disease like
bacterial, viral and fungal
22. Radioactive Application:
It are often beneficial for the embolisation of assorted liver
and spleen tumors which is employed for radio synvectomy
of local radiotherapy, arthritis, imaging of liver, bone
marrow, local radiotherapy and even imaging of thrombus in
deep vein thrombosis are often done. 13. Other Applications:
Fluorescent microspheres are often used for membrane
based technology flow cytometry, cell biology, fluorescent
linked immunosorbent assay. Yttrium 90 are often used for
primary treatment of carcinoma and also used for pre
transplant management of HCC with promising results.
23. Targeting by Using Micro Particulate Carriers:
The concept of targeting could be a well established dogma,
which is gaining full attention now a days. The response
produced by the drug depends on its access and interaction
with receptor usually pellets method is reported which
might be prepared by using extrusion / Spheronization
technology e.g. microcrystalline cellulose (MCC) and
chitosan.
24. Nasal drug delivery:
The nasal mucosa presents a perfect site for bioadhesive
drug delivery systems. Polymer based drug delivery systems,
like microspheres, liposomes and gels are demonstrated to
own good bioadhesive characteristics and swell easily when
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
in grips with the nasal mucosa increasing the bioavailability
and duration of the drugs to the nasal route. Various
polymer salts like chitosan lactate, chitosan aspartate,
chitosan glutamate and chitosan hydrochloride are good
candidates for nasal sustained release of vancomycin
hydrochloride. Nasal administration of Diphtheria Toxoid
incorporated into chitosan microparticles ends up in a
protective systemic and native immune reaction against
Diphtheria Toxic with enhanced IgG production. Nasal
formulations have induced significant serumIgG responses
just like secretary IgA levels, which are superior to
parenteral administration of the vaccine. Nasal absorption of
insulin after administration in to polymer powder were
found to be the foremost effective formulation for nasal drug
delivery of insulin in sheep compared to chitosan
nanoparticles and chitosan solution.
25. Intratumoral and native drug delivery:
Intratumoral and native drug delivery strategies have gained
momentum recently as apromising modality in cancer
therapy.
In order to deliver paclitax el at the tumor site in
therapeutically relevant concentration, polymer films were
fabricated. Paclitaxel can be loaded at 31% (w/w) in films,
which were translucent and versatile. polymer films
containing paclitaxels were obtained by casting method with
high loading efficiencies and also the chemical integrity of
molecule was unaltered during preparation in step with
study.
Result:
from this review, we can prepared micropsheres by using
different types of method of preparation.
Conclusion:
From this review, we could conclude that various types of
preparation methods along with its pharmaceutical
application are being used for Microspheres as a drug
delivery system for delivering the definite amount of
medications in a controlled manner. It may include oral,
targeted, sustained, topical, naso-pulmonary and various
biotechnology applications such as gene therapy etc. By
developing newer delivery technologies, it can give much
more therapeutic and commercial benefits by improving the
safety and reducing the toxicity. Today, many
pharmaceutical companies.
Drug absorption in the gastrointestinal tract is a highly
variable procedure and prolonging gastric retention of the
dosage form extends the time for drug absorption.
Microspheres by ionotropic gelation technique promises to
be potential approach for gastric retention. Although there
are number of difficulties to be worked out to achieve
prolonged gastric retention, a large number of companies
are focusing toward commercializing this technique.
To accomplish the traditional coacervation, new methods
have been developed (freeze-drying,spray drying,
microfluidic flow-focusing, lithography, etc.). The various
created structures a large potential for the fine-tuning of
drug release mechanisms and the optimization of the
pharmacokinetic profile.
Volume – 5 | Issue – 1
|
November-December 2020
Page 139
International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
Reference:
[1] Jamini M and Rawat S: A review on microsphere, Res.
J. Pharm. Boils. Chem. Sci. 2013; 4(1): 1223-33.
[2]
Patel NR, Patel DA, Bharadia PD, Pandya V and Modi
D: Microsphere as a novel drug delivery, Int. J. Pharm.
Life Sci. 2011; 2(8): 992-7.
[3]
Singh C, Purohit S, Singh M and Pandey BL: Design
and evaluation of microspheres: A Review, Jour. of
Drug Deli. and Res. 2013; 2(2): 18-27.
[4]
Ghulam M, Mahmood A, Naveed A, Fatima R.2009.
Comparative study of various microencapsulation
techniques. Effect of polymer viscosity on
microcapsule characteristics, Pak. J. Sci. 22 (3):291300
[5]
[6]
Mathew T, Devi S, Prasanth V, Vinod B. 2010.
Suitability of factorial design in determining the
processing factors affecting entrapment efficiency of
albumin microspheres. J Pharm Res. 3(5):1172- 1177
Mathew T, Devi S, Prasanth V, Vinod B. 2008. NSAIDs
as microspheres. The Internet Journal of
Pharmacology.6(1)
[7]
Karmakar U, Faysal M. 2009. Diclofenac as
microspheres. The Internet Journal of Third World
Medicine. 8(1)
[8]
CN 201110142359, Zhu LiminSciasciaNie Shen Wei,
Publication: 28-09-11
[9]
CN 201110313846, Xiao Guomin Ho Yi Chen Lihua
Chen Danfeng, Publication: 03-04-13
[10]
CN 201210025085, High Baojiao door Jane Rui Xin
Jianjun, Publication: 20-013
[11]
US08455091, Rocio Herrero-Vanrell Miguel F. Refojo,
Publication: 17-02-98
[12]
EP19980924438, Lisbeth Illum He Univ. Quebec
Montreal PING, Publication: 14-07-04
[13]
EP20070808011, Hong KeeSah, Publication: 03-04-13
[14]
CA 2217462, ZebunnissaRamtoola, Publication: 0308-10
[15]
CA 2579533, Andrew Lennard Lewis Peter William
Stratford Maria Victoria Gonzalez-Fajardo Yiqing
Tang, Publication: 06-09-05
[16]
DE1999609777, Publication: 15-04-04
[17]
DE1994632867, Yan Chen Bruce Nathaniel Gray,
Publication: 22-04-04
[18]
Kavita K, RajeV, et al. 2010. Albumin Microspheres: A
Unique system as drug delivery carriers for non
steroidal anti-inflammatory drugs. 5(2):12
[19]
Khar R. K, Vyas, S. P. 2002. Targeted and Controlled
Drug Delivery- Novel Carrier Systems., 1st edition,
CBS Publications and Distributors, New Delhi; 417418.
[20]
Kreuter J, Nefzger M, Liehl E, CzokR,Voges R. 2010. J.
Pharm Sci.72; 11-46.
[21]
Margel S, Wiesel E. 2010. JPolym Sci.1983;22:145
[22]
Sugibayashi K, Akimoto M, Moromoto Y, Nadai T, Kato
Y. 1979.Pharmacobiodyn. 23: 50
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
[23]
Yoshioka T, Hashida M, MuranishiS,Sezaki H. Int. J.
pharm. 1981;8:131.
[24]
www.pharmainfo.net/reviews/bioadhesivemicrosph
eresreview, Patel JK, Patel RP, Amin AF, Patel MM,
4(6)
[25]
Bale, S.; Khurana, A.; Reddy, A. S. S.; Singh, M.; Godugu,
C. Overview on Therapeutic Applications of
icroparticle Drug Delivery Overview on Therapeutic
Applications of Microparticulate Drug Delivery
Systems. Crit. Rev. Ther. Drug Carr. Syst. 2016, 4, 309–
361. [CrossRef] [PubMed]
[26]
Wang, B. H.; Longquin Hu, T. J. S. Drug Delivery to the
Lymphatic System. In Drug Delivery Principles and
Applications; Wang, B., Longquin Hu, T.J.S., Eds.; John
Wiley and Sons Inc.: Hoboken, NJ, USA, 2016; p. 509.
ISBN 9781118833230.
[27]
Whelehan, M.; Marison, I.W. Microencapsulation using
vibrating technology. J. Microencapsul. 2011, 28, 669–
688. [CrossRef] [PubMed]
[28]
Peanparkdee, M.; Iwamoto, S.; Yamauchi, R.
Microencapsulation: A Review of Applications in the
Food and Pharmaceutical Industries. Rev. Agric. Sci.
2016, 4, 56–65. [CrossRef]
[29]
Desai, T.; Shea, L. D. Advances in islet encapsulation
technologies. Nat. Publ. Gr. 2016, 16, 338–350.
[CrossRef] [PubMed]
[30]
Yi, Y.; Sanchez, L.; Gao, Y.; Yu, Y. Janus particles for
biological imaging and sensing. Analyst 2016, 141,
3530–3539. [CrossRef] [PubMed] Sci. Pharm. 2019,
87, 20 25 of 31
[31]
Acter, S.; Cho, J.; Kim, J. W.; Byun, A.; Park, K. H.; Kim, J.
W. Synthesis and shape control of uniform polymer
microparticles
by
tailored
adsorption
of
poly(ethylene
oxide)-b-poly("-caprolactone)
copolymer. Bull. Korean Chem. Soc. 2015, 36, 1467–
1473. [CrossRef]
[32]
Gong, Z.; Hueckel, T.; Yi, G.R.; Sacanna, S. Patchy
particles made by colloidal fusion. Nature 2017, 550,
234–238. [CrossRef]
[33]
Choi, K.; Salehizadeh, M.; Da Silva, R.B.; Hakimi, N.;
Diller, E.; Hwang, D. K. 3D shape evolution of
microparticles and 3D enabled applications using
non-uniform UV flow lithography (NUFL). Soft Matter
2017, 13, 7255–7263. [CrossRef]
[34]
Karami, N.; Moghimipour, E.; Salimi, A. Liposomes as a
Novel Drug Delivery System: Fundamental and
Pharmaceutical Application. Asian J. Pharm. 2018, 12,
S31–S41.
[35]
Rosenberg, R. T.; Dan, N. R. Di_usion through colloid
some shells. J. Colloid Interface Sci. 2011, 354, 478–
482.[CrossRef]
[36]
36.Yuan, Q.; Cayre, O.J.; Fujii, S.; Armes, S. P.; Williams,
R.A.; Biggs, S. Responsive core-shell latex particles as
colloid some microcapsule membranes. Langmuir
2010, 26, 18408–18414. [CrossRef] [PubMed]
[37]
Ozturk, A. G.; Ozturk, S. S.; Palsson, B. O.; Wheatley, T.
A.; Dressman, J. B. Mechanism of release from pellets
Volume – 5 | Issue – 1
|
November-December 2020
Page 140
International Journal of Trend in Scientific Research and Development (IJTSRD) @ www.ijtsrd.com eISSN: 2456-6470
Review, International Journal of Pharm Tech
Research. 2(1):675-681.
coated with an ethyl cellulose-based film. J. Control.
Release 1990, 14, 203–213. [CrossRef]
[48]
Najmuddin M, Ahmed A, Shelar S, Patel V, Khan
T.2010. Floating Microspheres Of Ketoprofen:
Formulation and Evaluation, International Journal Of
Pharmacy and Pharmaceutical sciences. 2(2):83-87.
[49]
Doty, A. C. Mechanistic Analysis of In Vivo and In Vitro
Drug Release from PLGA Microspheres. Ph.D.Thesis,
University of Michigan, Ann Arbor, ML, USA, 2015.
http://www.springerlink.com/content/r883r91q175
76vx6/ DOI: 10.1007/0-306- 46891-3_9, Hafeli U,
2002, Physics and Chemistry Basic of Biotechnology.
Focus on biotechnology Review. Radioactive
Microspheres for Medical Application, 7:213-248.
[50]
Bennet, D.; Kim, S. E. I. Application of Nanotechnology
in Drug Delivery. In Polymer Nanoparticles for Smart
Drug Delivery; Sezer, A.D., Ed.; In Tech Open: London,
UK, 2014; ISBN 978-953-51-1628-8 b.
Yadav AV, Mote HH. 2008. Development of
Biodegradable Starch Microspheres for Intranasal
Delivery, Indian Journal of pharmaceutical Sciences.
70 (2):170-174.
[51]
Senyei, A.; Widder, K.; Czerlinski, G. Magnetic
guidance of drug-carrying microspheres. J. Appl. Phys.
1978, 49, 3578–3583. [CrossRef]
Saralidze K, Leo H, Koole, Menno L, Knetsch W. 2010.
Polymeric Microspheres for Medical Applications,
Materials. 3:3357- 3564.
[52]
Farah, F. H. Magnetic Microspheres: A Novel Drug
Delivery System. World, J. Pharm. Pharm. Sci. 2017, 3,
93–112. [CrossRef]
Trivedi P, VermaL, Garud N. 2008.Preparation and
Characterization of Acclofenac Microspheres, Asian
Journal of pharmaceutics. 2(2): 110-115.
[53]
Alagusundaram M, Madhu C, Umashankari K, Attuluri
B, Lavanya C, Ramkanth S. Microspheres: As novel
drug delivery system. International Journal of Chem
Tech Research. 2009; 1(3): 526-534
[54]
Kannan. K., Karar. K. P., Manavalan. R., Formulation
and Evaluation of Sustained Release Microspheres of
Acetazolamide by Solvent Evaporation Technique, J.
Pharm.Sci& Res. 2009; 1 (1):36-39.
[55]
Shaji J., Poddar A., Iyer S., Brain-Targeted Nasal
Microspheres, Indian Journal of pharmaceutical
Sciences. 2009; 71(6): 715–718.
[56]
Chowdary K. P. R., Suri B. J., Permeability of Ethylene.
[38]
Tang, E. S. K.; Chan, L. W.; Heng, P. W. S. Coating of
multiparticulates for sustained release. Am. J. Drug
Delivery 2005, 3, 17–28. [CrossRef]
[39]
Prajapati, V. D.; Jani, G. K.; Kapadia, J. R. Current
knowledge on biodegradable microspheres in drug
delivery. Expert Opin. Drug Deliv. 2015, 12, 1283–
1299. [CrossRef] [PubMed]
[40]
[41]
[42]
[43]
[44]
Foox, M.; Zilberman, M. Drug delivery from gelatinbased systems. Expert Opin. Drug Deliv. 2015, 12,
1547–1563. [CrossRef]
[45]
Rowe, R. C.; Sheskey, P.; Quinn, M. Handbook of
Pharmaceutical Excipients, 7th ed.; Rowe, R.C.,
Sheskey
[46]
Li S. P, Kowalski C. R, Feld K. M, Grim W.M.
1988.Recent Advances in Microencapsulation
Technology and Equipment, Drug Dev Ind Pharm. 14:
353-376.
[47]
Shanthi N. C, Gupta R, Mahato K. A. 2010 Traditional
and Emerging Applications of Microspheres: A
@ IJTSRD
|
Unique Paper ID – IJTSRD35866
|
Volume – 5 | Issue – 1
|
November-December 2020
Page 141